Ascend Wellness Holdings, Inc.
Rank #367DeclineAAWH · OTC · Healthcare
Ascend Wellness Holdings, Inc. (AAWH) — Rank #367 by gross profitability (GP/assets 0.19) · ROE 137.6% · Piotroski F-Score 5 / 9.
As-of 2026-09-15 · CIK 0001756390 · all metrics point-in-time as of the filing date.
About
Ascend Wellness Holdings, Inc. engages in the cultivation, manufacture, and distribution of cannabis consumer packaged goods in the United States.
Show moreShow less
The company offers flower, pre-rolls, concentrates, vapes, edibles, tablets, and other cannabis-related products under the Common Goods, SimplyHerb, Ozone, Royale, High Wired, Effin', Miss Grass, Lowell Smokes, Flower by Edie Parker, 1906, AiroPro, and Miss Grass brands. It also owns, operates, and manages cannabis cultivation facilities and dispensaries. The company sells its products through company-owned retail stores, and third-party licensed retail cannabis stores. The company was formerly known as Ascend Wellness Holdings, LLC and changed its name to Ascend Wellness Holdings, Inc. in April 2021. Ascend Wellness Holdings, Inc.
was incorporated in 2018 and is headquartered in Rochelle Park, New Jersey.
- Industry
- Drug Manufacturers - Specialty & Generic
- Sector
- Healthcare
- State
- DE
- Filer Category
- Emerging growth company
- Fiscal Year End
- December 31
- Website
- awholdings.com
Financials
Strengthening
Direction over 5 fiscal years
- Free cash flowimproving
- Gross margindeteriorating
- Gross profitabilitystable
- Net cashimproving
- Operating marginimproving
- Return on equityimproving
- Share count (dilution)improving
Monitoring diagnostic of business direction — not a prediction of returns.
Each fiscal year is read as-of that year’s own 10-K filing, so nothing restated after the fact leaks backwards. Line items this filer never tagged are omitted. Hover or tap a badge for the diagnostic behind it.
| Fiscal year end | 2025-12-31filed 2026-03-12 | 2024-12-31filed 2025-03-13 | 2023-12-31filed 2024-03-13 | 2022-12-31filed 2023-03-15 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 500.6 | 561.6 | 518.6 | 405.9 |
| Revenue growth (YoY) | -10.9% | 8.3% | 27.8% | 22.1% |
| Gross profit | 169.7 | 184.2 | 155.1 | 134.6 |
| Gross margin | 33.9% | 32.8% | 29.9% | 33.1% |
| Net income | (118.2) | (85.0) | (48.2) | (80.9) |
| Net margin | -23.6% | -15.1% | -9.3% | -19.9% |
| EPS (diluted) | -$0.58 | -$0.40 | -$0.24 | -$0.44 |
| EPS growth (YoY) | -45.0% | -66.7% | 45.5% | — |
| Cash flow | ||||
| Operating cash flow | 38.1 | 73.3 | 75.3 | (38.4) |
| Capital expenditures | 26.0 | 22.5 | 24.2 | 81.6 |
| Free cash flow | 12.0 | 50.8 | 51.1 | (120.0) |
Figures are as originally filed with the SEC (point-in-time), not restated, so they can differ slightly from sites that show later-restated numbers. Why point-in-time?